The Biomarker Potential of miRNAs in Myotonic Dystrophy Type I
MicroRNAs (miRNAs) are mostly known for their gene regulation properties, but they also play an important role in intercellular signaling. This means that they can be found in bodily fluids, giving them excellent biomarker potential. Myotonic Dystrophy type I (DM1) is the most frequent autosomal dom...
Main Authors: | Emma Koehorst, Alfonsina Ballester-Lopez, Virginia Arechavala-Gomeza, Alicia Martínez-Piñeiro, Gisela Nogales-Gadea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/12/3939 |
Similar Items
-
miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1
by: Demetris Koutalianos, et al.
Published: (2021-12-01) -
An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I
by: Andrea López-Martínez, et al.
Published: (2020-09-01) -
Non-Coding RNAs in Muscle Dystrophies
by: Alessandra Ferlini, et al.
Published: (2013-09-01) -
A Patient with Myotonic Dystrophy Type 1 Presenting as Parkinsonism
by: Ji-Hyun Choi, et al.
Published: (2018-09-01) -
Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy
by: Estefanía Cerro-Herreros, et al.
Published: (2020-09-01)